文献速递临床试验与 GCP流行病学与生物统计

开辟糖尿病预防新路径(FINDIT):一项随机对照试验的研究方案

ForgIng New paths in DIabetes PrevenTion (FINDIT): Study Protocol for a Randomized Controlled Trial.
PubMed 文献 · Trials · 2017-04-08

该平行设计随机对照试验计划从安娜堡退伍军人医疗中心招募315例非糖尿病但具有2型糖尿病主要风险因素且过去12个月未行HbA1c筛查的患者。参与者被随机分为两组:在下次初级保健就诊时接受HbA1c筛查及标准化简短咨询,或阅读临床预防服务手册。主要结局为12个月后体重变化,次要结局包括风险感知、知识、自我效能、动机、药物使用、体力活动、体重管理项目参与及心理健康。

要点

  • 计划招募315例具有2型糖尿病风险因素且12个月内未筛查HbA1c的非糖尿病患者。
  • 干预组在初级保健就诊时接受HbA1c筛查和标准化简短咨询,对照组阅读预防服务手册。
  • 主要结局为12个月体重变化,次要结局涵盖风险感知、知识、自我效能、动机、药物使用、体力活动、体重管理参与和心理健康。

核心结论

  • 该试验将生成关于糖尿病前期诊断和简短咨询对患者预防行为及其中介因素影响的基础数据,从而有助于开发提高患者参与2型糖尿病预防的新策略。

研究设计与样本

  • 平行设计随机对照试验,计划从安娜堡退伍军人医疗中心招募315例非糖尿病患者,这些患者具有一个或多个2型糖尿病主要风险因素、有即将到来的初级保健预约且过去12个月未行HbA1c筛查。

主要发现

  • 原文未报告结果。

关键数值与推荐

  • 主要结局为初级保健就诊后12个月的体重变化。
  • 次要结局包括2型糖尿病风险感知变化、2型糖尿病预防知识、预防2型糖尿病的自我效能和动机、2型糖尿病预防药物使用、体力活动、体重管理项目参与以及心理健康。
  • 定量分析将比较HbA1c检测组中被发现为糖尿病前期的参与者与手册组参与者的结局。
  • 在HbA1c检测组中被发现为糖尿病前期的参与者中,将进行半结构化访谈,了解他们对收到糖尿病前期诊断的理解和反应。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prediabetes is an asymptomatic condition in which patients' blood glucose levels are higher than normal but do not meet diagnostic criteria for type 2 diabetes mellitus (T2DM). A key window of opportunity to increase engagement of patients with prediabetes in strategies to prevent T2DM is when they are screened for T2DM and found to have prediabetes, yet the effects of this screening and brief counseling are unknown. METHODS: In this parallel-design randomized controlled trial we will recruit 315 non-diabetic patients from the Ann Arbor VA Medical Center (AAVA) who have one or major risk factors for T2DM and an upcoming primary care appointment at the AAVA, but have not had a hemoglobin A1c (HbA1c) test to screen for T2DM in the previous 12 months. After informed consent, participants will complete a baseline survey and be randomly assigned to, at the time of their next primary care appointment, one of two arms: (1) to have a hemoglobin A1c (HbA1c) test to screen for T2DM and receive brief, standardized counseling about these results or (2) to review a brochure about clinical preventive services. Participants will complete surveys 2 weeks, 3 months, and 12 months after their primary care appointment, and a weight measurement 12 months after their primary care appointment. The primary outcome is weight change after 12 months. The secondary outcomes are changes in perception of risk for T2DM; knowledge of T2DM prevention; self-efficacy and motivation to prevent T2DM; use of pharmacotherapy for T2DM prevention; physical activity; participation in weight management programs; and mental health. Quantitative analyses will compare outcomes among participants in the HbA1c test arm found to have prediabetes with participants in the brochure arm. Among participants in the HbA1c test arm found to have prediabetes we will conduct semi-structured interviews about their understanding of and reactions to receiving a prediabetes diagnosis. DISCUSSION: This trial will generate foundational data on the effects of a prediabetes diagnosis and brief counseling on patients' preventive behaviors and mediators of these behaviors that will enable the development of novel strategies to improve patient engagement in T2DM prevention. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02747108 . Registered on 18 April 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kullgren JT, Youles B, Shetty S, et al. ForgIng New paths in DIabetes PrevenTion (FINDIT): Study Protocol for a Randomized Controlled Trial. Trials. 2017. PMID: 28388933. doi:10.1186/s13063-017-1887-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。